Rosas HD - Search Results

1

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM. Rosas HD, et al. Neurology. 2003 May 27;60(10):1615-20. doi: 10.1212/01.wnl.0000065888.88988.6e. Neurology. 2003. PMID: 12771251

2

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers.

Jenkins BG, Rosas HD, Chen YC, Makabe T, Myers R, MacDonald M, Rosen BR, Beal MF, Koroshetz WJ. Jenkins BG, et al. Among authors: rosas hd. Neurology. 1998 May;50(5):1357-65. doi: 10.1212/wnl.50.5.1357. Neurology. 1998. PMID: 9595987

3

Riluzole therapy in Huntington's disease (HD).

Rosas HD, Koroshetz WJ, Jenkins BG, Chen YI, Hayden DL, Beal MF, Cudkowicz ME. Rosas HD, et al. Mov Disord. 1999 Mar;14(2):326-30. doi: 10.1002/1531-8257(199903)14:2<326::aid-mds1019>3.0.co;2-q. Mov Disord. 1999. PMID: 10091628 Clinical Trial.

4

An integrated strategy for evaluation of metabolic and oxidative defects in neurodegenerative illness using magnetic resonance techniques.

Jenkins BG, Chen YI, Kuestermann E, Makris NM, Nguyen TV, Kraft E, Brownell AL, Rosas HD, Kennedy DN, Rosen BR, Koroshetz WJ, Beal MF. Jenkins BG, et al. Among authors: rosas hd. Ann N Y Acad Sci. 1999;893:214-42. doi: 10.1111/j.1749-6632.1999.tb07828.x. Ann N Y Acad Sci. 1999. PMID: 10672240 Review.

5

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.

Rosas HD, Goodman J, Chen YI, Jenkins BG, Kennedy DN, Makris N, Patti M, Seidman LJ, Beal MF, Koroshetz WJ. Rosas HD, et al. Neurology. 2001 Sep 25;57(6):1025-8. doi: 10.1212/wnl.57.6.1025. Neurology. 2001. PMID: 11571328

6

Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. Rosas HD, et al. Neurology. 2002 Mar 12;58(5):695-701. doi: 10.1212/wnl.58.5.695. Neurology. 2002. PMID: 11889230

7

Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.

Rosas HD, Feigin AS, Hersch SM. Rosas HD, et al. NeuroRx. 2004 Apr;1(2):263-72. doi: 10.1602/neurorx.1.2.263. NeuroRx. 2004. PMID: 15717027 Free PMC article. Review.

8

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.

Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Rosas HD, et al. Neurology. 2005 Sep 13;65(5):745-7. doi: 10.1212/01.wnl.0000174432.87383.87. Neurology. 2005. PMID: 16157910

9

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, Zaleta A, Kaneko Y, Jenkins B, Hevelone N, Zhang H, Yu H, Schoenfeld D, Ferrante R, Rosas HD. Hersch SM, et al. Among authors: rosas hd. Neurology. 2006 Jan 24;66(2):250-2. doi: 10.1212/01.wnl.0000194318.74946.b6. Neurology. 2006. PMID: 16434666 Clinical Trial.

10

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.

Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH. Rosas HD, et al. Mov Disord. 2006 Sep;21(9):1317-25. doi: 10.1002/mds.20979. Mov Disord. 2006. PMID: 16755582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters